Skip to content
Screener

Eikon Therapeutics, Inc. EIKN Q2 2026 earnings

Reported August 13, 2026 · After market close

EPS-$1.63Miss by $0.05
EPS estimate-$1.58

Next report

Nov 12, 2026 (in a month)
EPS estimate-$1.74

Versus estimates

Diluted EPS

Q2 2026-$1.63Miss by $0.05
Q4 2025-$27.00Miss by $23.44

FAQ

When did Eikon Therapeutics, Inc. report Q2 2026 earnings?
Eikon Therapeutics, Inc. (EIKN) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Eikon Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Eikon Therapeutics, Inc. reported eps of $-1.63 for Q2 2026.
Did Eikon Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-1.58 by $0.05.
Where can I find Eikon Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-349154) and the 10-Q periodic report (0001193125-26-349185) directly on SEC EDGAR. The filing index links above go to sec.gov.